What's new

Human medicines European public assessment report (EPAR): Sunlenca, lenacapavir, Date of authorisation: 17/08/2022, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Sunlenca, lenacapavir, Date of authorisation: 17/08/2022, Revision: 5, Status: Authorised

Feb 26, 2025 - 13:45
 0
Human medicines European public assessment report (EPAR): Sunlenca, lenacapavir, Date of authorisation: 17/08/2022, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Sunlenca, lenacapavir, Date of authorisation: 17/08/2022, Revision: 5, Status: Authorised
Read More

Tags:

Previous Article

Auto Trader expands Co-Driver with two new AI powered vehicle advert tools

Next Article

Human medicines European public assessment report (EPAR): Sitagliptin SUN, sitag...

Related Posts

Opinion/decision on a Paediatric investigation plan (PIP): Rapiscan, Regadenoson, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Surgical and medical procedures, PIP number: P/0029/2024

Opinion/decision on a Paediatric investigation plan (PI...

Mar 18, 2025  0

Website outages and upgrades

Website outages and upgrades

Feb 25, 2025  0

Substances considered as not falling within the scope o...

Feb 21, 2025  0